Share on StockTwits

Lumenis (NASDAQ:LMNS) announced its earnings results on Monday. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.11 by $0.02, Analyst Ratings Network reports. The company had revenue of $72.50 million for the quarter, compared to the consensus estimate of $70.30 million. Lumenis’s revenue was up 9.4% compared to the same quarter last year. Lumenis updated its FY14 guidance to $0.51-$0.55 EPS.

Lumenis (NASDAQ:LMNS) traded up 2.11% during mid-day trading on Monday, hitting $9.18. 25,166 shares of the company’s stock traded hands. Lumenis has a 1-year low of $8.16 and a 1-year high of $13.38. The stock has a 50-day moving average of $9.32 and a 200-day moving average of $9.85. The company has a market cap of $283.3 million and a P/E ratio of 19.09.

Lumenis Ltd. is a provider of energy-based, minimally invasive clinical solutions. The Company operated in three segments: surgical, ophthalmic and aesthetic.

Receive News & Ratings for Lumenis Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumenis Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.